Supriya Lifescience Limited (NSE:SUPRIYA)

India flag India · Delayed Price · Currency is INR
736.90
+10.70 (1.47%)
Jan 22, 2026, 9:50 AM IST
1.13%
Market Cap58.45B
Revenue (ttm)7.15B
Net Income (ttm)1.82B
Shares Out80.48M
EPS (ttm)22.69
PE Ratio32.00
Forward PE28.04
Dividend1.00 (0.14%)
Ex-Dividend DateSep 4, 2025
Volume12,682
Average Volume132,980
Open729.80
Previous Close726.20
Day's Range727.80 - 739.00
52-Week Range556.15 - 842.00
Beta0.27
RSI44.81
Earnings DateFeb 11, 2026

About Supriya Lifescience

Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1987
Employees 515
Stock Exchange National Stock Exchange of India
Ticker Symbol SUPRIYA
Full Company Profile

Financial Performance

In 2024, Supriya Lifescience's revenue was 6.96 billion, an increase of 22.12% compared to the previous year's 5.70 billion. Earnings were 1.88 billion, an increase of 57.80%.

Financial Statements